Kolexia
Azzopardi Nicolas
Maladies infectieuses
CHU Tours
Tours, France
35 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs du côlon Tumeurs du rectum Métastase tumorale Leucémie chronique lymphocytaire à cellules B Arthrite Télangiectasie hémorragique héréditaire Télangiectasie Polyarthrite rhumatoïde

Industries

MSD
1 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Albumin influences leucocyte FcRn expression in the early days of kidney transplantation.
Clinical and experimental immunology   13 février 2024
Confounding mitigation for the exposure-response relationship of bevacizumab in colorectal cancer patients.
British journal of clinical pharmacology   10 décembre 2023
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
Journal of internal medicine   23 août 2023
Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients.
Clinical pharmacokinetics   13 juillet 2023
Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials.
RMD open   04 janvier 2022
Relationship Between Antithymocyte Globulin Concentrations and Lymphocyte Sub-Populations in Kidney Transplant Patients.
Clinical pharmacokinetics   22 juillet 2021
Fate of trastuzumab after intrathecal administrations: a possible influence of antigen mass
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
LDL cholesterol decrease by anti-PCSK9 monoclonal antibodies: Systematic review, meta-analysis and meta-regression of randomized controlled trials
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited.
Clinical pharmacokinetics   24 mai 2021
Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration.
Clinical pharmacology and therapeutics   31 mars 2021